102 results
8-K
EX-99.1
VIR
Vir Biotechnology Inc
18 Apr 24
Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy
8:44am
as a biotech executive and in research and development leadership roles to the industry. He is currently President and Chief Executive Officer, and a member … , and only a small number of research and development programs result in commercialization of a product. Results in early-stage clinical trials may
8-K
EX-99.1
VIR
Vir Biotechnology Inc
22 Feb 24
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
4:12pm
); Biomedical Advanced Research and Development Authority (BARDA), under Other Transaction Number: 75A50122C00081.
Influenza
The full analysis of data from … of sotrovimab.
Research and Development Expenses (R&D): R&D expenses for the fourth quarter of 2023 were $111.9 million, which included severance
8-K
VIR
Vir Biotechnology Inc
13 Dec 23
Cost Associated with Exit or Disposal Activities
4:06pm
. The reductions will be substantially complete by the first quarter of 2024.
The Company is also closing its research and development facilities in St … litigation or other disputes. Drug development and commercialization involve a high degree of risk, and only a small number of research and development
S-3ASR
ptzmkj7vmw9 n5sjs
3 Nov 23
Automatic shelf registration
4:33pm
8-K
EX-99.1
k4pzq9eyvsz
2 Nov 23
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
4:09pm
8-K
wej2o7tatqach z6xc8a
3 Oct 23
Entry into a Material Definitive Agreement
8:01am
8-K
EX-99.1
vh2z4h4lozn ph
3 Aug 23
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2023 Financial Results
4:14pm
8-K
EX-99.1
xiqjfkh2jfbk6j2qd
20 Jul 23
Vir Biotechnology Announces Topline Data from Phase 2 PENINSULA Trial Evaluating
8:04am
8-K
n51h25r1 fc7dki59kw
20 Jul 23
Vir Biotechnology Announces Topline Data from Phase 2 PENINSULA Trial Evaluating
8:04am
8-K
EX-99.1
lyd6ry81zzw5qx8oxc44
4 May 23
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:16pm